Topical Heparin Therapy in Stasis Ul cer: A Case Report

Özlem Keskin^1, , Ahmet Karagöz², Kadir Öymen Hançerlioğulları³, Alptekin Tosun⁴ and İlker İlhanlı⁵

¹Department of Cardiovascular surgery, Giresun University, Giresun, Turkey,

²Department of Cardiology, Giresun University, Giresun, Turkey

³Department of Pediatric Surgery, Giresun University, Giresun, Turkey

⁴Department of Radiology, Giresun University, Giresun, Turkey

⁵Department of Physical Therapy and Rehabilitation, Giresun University, Giresun, Turkey

Cite this paper

Özlem Keskin, Ahmet Karagöz, Kadir Öymen Hançerlioğulları, Alptekin Tosun and İlker İlhanlı. Topical Heparin Therapy in Stasis Ul cer: A Case Report. American Journal of Medical Case Reports. 2015; 3(1):18-19. doi: 10.12691/AJMCR-3-1-7

Abstract

Venous leg ulcers are the late and severe clinical form of chronic venous disease. Superficial venous system, deep venous system or perforating veins between them which are affected by reflux, obstruction or inability of the muscle pump, play an important role in pathophysiology. Compression bandages and wound care are the basis of treatment for venous ulcers. For ulcers which do not respond to these treatments, surgical procedures may be considered. There is a need for a multidisciplinary approach for the treatment and follow-up of venous leg ulcers. Cutaneous lesions like stasis ulcer are common in patients with chronic renal failure. Healing of chronic ulcer is difficult and can take time. Here we emphasized the effects of topical use of un-fractionated heparin on wound healing of an elderly male patient with chronic renal failure.

Keywords

stasis ulcer, chronic renal failure, heparin

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Saliba MJ Jr. The effects and uses of heparin in the care of burns that improves treatment and enhances the quality of life. Acta Chir Plast. 1997; 39: 13-6.
[2]	Agbenorku P, Fugar S, Akpaloo J, Hoyte-Williams PE, Alhassan Z, Agyei F. Management of severe burn injuries with topical heparin: the first evidence-based study in Ghana. Int J Burns Trauma. 2013; 3(1): 30-6. Epub 2013 Jan 24.
[3]	De Cock R, Ficker LA, Dart JG, Garner A, Wright P. Topical heparin in the treatment of ligneous conjunctivitis. Ophthalmology. 1995 Nov; 102(11): 1654-9.
[4]	Hiebert LM, Lui JM. Heparin protects cultured arterial endothelial cells from damage by toxic oxygen metabolites. Arteriosclerosis. 1990; 83: 37-51.
[5]	Kritikos O, Tsagarakis M, Tsoutsos D, Kittas C, Gorgoulis V, Papalois A et al. O. The efficacy of recombinant human activated protein C (rhAPC) vs antithrombin III (at III) vs heparin, in the healing process of partial-thickness burns: a comparative study. Ann Burns Fire Disasters. 2012 Jun 30; 25(2): 66-73.